Cart
sales@molnova.com
DHQ
CAS No. 15804-19-0
DHQ( 2,3-dihydroxy-quinoxalin )
Catalog No. M27269 CAS No. 15804-19-0
DHQ is an inducer of ATPase activity that of Herpes Simplex Virus thymidine kinase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 35 | In Stock |
|
| 50MG | 58 | In Stock |
|
| 100MG | 88 | In Stock |
|
| 200MG | 140 | In Stock |
|
| 500MG | 236 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDHQ
-
NoteResearch use only, not for human use.
-
Brief DescriptionDHQ is an inducer of ATPase activity that of Herpes Simplex Virus thymidine kinase.
-
DescriptionDHQ is an inducer of ATPase activity that of Herpes Simplex Virus thymidine kinase.
-
In Vitro2,3-Dihydroxyquinoxaline (DHQX) shows an intense fluorescence at λex/λem = 328/414 nm.
-
In Vivo——
-
Synonyms2,3-dihydroxy-quinoxalin
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15804-19-0
-
Formula Weight162.148
-
Molecular FormulaC8H6N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=c1[nH]c2ccccc2[nH]c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Paederosidic acid me...
Paederosidic acid methyl ester has antinociception, is possibly related to the pathway of NO-cGMP-ATP sensitive K(+) channels.
-
Omecamtiv mecarbil
Omecamtiv mecarbil (CK-1827452) is the first potent cardiac myosin activator that can specifically activate the cardiac myosin S1 domain but not other muscle myosins.
-
NDI-091143
NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
